The promise of asexual malaria vaccine development.
This review presents several reasons to support the belief that an asexual vaccine for human malaria caused by Plasmodium falciparum will be developed. It lists many of the current vaccine candidates that we think are ready for human trials and it summarizes a strategy for the development of an asexual vaccine.
Pasloske
B L
BL
Affymax Research Institute, Santa Clara, California.
Howard
R J
RJ
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology; D000882:Haplorhini; D006801:Humans; D017780:Malaria Vaccines / Q000276:immunology; D016778:Malaria, Falciparum / Q000517:prevention & control*; D010963:Plasmodium falciparum / Q000235:genetics / Q000276:immunology*; D015800:Protozoan Proteins / Q000276:immunology; D016052:Protozoan Vaccines
D000953:Antigens, Protozoan; D017780:Malaria Vaccines; D015800:Protozoan Proteins; D016052:Protozoan Vaccines